Comparative Effects of Four Dietary Approaches on Symptom Severity and Quality of Life in Irritable Bowel Syndrome: A Randomized Controlled Trial

Why they ran it

Traditional dietary advice, the low FODMAP diet and the gluten free diet are all used routinely in irritable bowel syndrome clinics, but comparative evidence on how they perform against each other is limited, and thinner still when they are combined.

That gap matters because clinicians have to pick one approach first without knowing which does more for symptoms or for quality of life.

Drawn from the background section of the paper's abstract.

Adults aged 19 to 65 with irritable bowel syndrome diagnosed by Rome IV criteria were recruited from a university hospital gastroenterology clinic and allocated to one of four plans for four weeks: traditional dietary advice, a low FODMAP diet, a gluten free diet, or the two combined. Participants were not told the name of the diet they had been given, and the people scoring the outcomes did not know the allocation. The main measures were the symptom severity score and a quality of life questionnaire, with stool form, body mass index and intake frequency scores alongside.

Every group improved. Symptom severity fell within all four arms, and the reductions in the low FODMAP arm and the combined low FODMAP gluten free arm were significantly larger than in the traditional advice arm. The responder split is the sharpest number in the paper. Everyone on the low FODMAP, gluten free and combined plans cleared the threshold of a 50 point drop in symptom score, against 8 of 13 people, or 61.5 percent, on traditional advice. Quality of life rose in all four groups with no significant difference between them.

Two details are worth carrying. This is the restriction phase only, four weeks with no reintroduction step and no follow up, so it says nothing about where people land once foods come back in. And the quality of life result cuts against a simple ranking, because the arm with the weakest effect on symptoms delivered the same improvement in day to day life as the strictest one. The authors read all of this as an argument for a stepwise, individual approach.

The numbers

undefined	undefined
undefined	undefined
undefined	undefined
undefined	undefined

Why this might happen

Not available The full discussion is not openly available and the abstract offers no mechanism, so we do not know what the authors think caused this.

The authors do not offer an explanation we can point to, so we are not going to invent one.

The study did record stool form and body mass index alongside intake scores, and reported no significant differences between groups on either.

Drawn from no reachable discussion, the abstract was the deepest source available.

What this does not show

This does not establish low FODMAP as the diet to reach for first. The trial covers the four week restriction phase alone. There was no reintroduction phase, no personalisation step and no follow up, which is where most of the practical question about long term management sits.
It does not show that adding gluten free on top of low FODMAP helps. The only symptom comparisons reported as significant were the low FODMAP and the combined arms against traditional advice. No advantage of the combined plan over low FODMAP alone was reported.
No diet came out ahead on quality of life. Quality of life scores improved within every arm, but the between group comparison landed at p equals 0.082, so none of the four separated from the others on that measure.
It cannot speak to how nutritionally complete these plans were. The measures tracked alongside symptoms were body mass index, stool form and intake frequency. Fibre intake, micronutrient status and gut bacteria were not reported.

Where this leaves us

It is now more likely that a four week low FODMAP restriction, alone or combined with gluten removal, cuts symptom severity further than traditional dietary advice does, while quality of life improves under any of the four approaches. That puts the measurable advantage in the symptom column and not the quality of life column.

Adults aged 19 to 65 with Rome IV irritable bowel syndrome at a single university hospital clinic in Turkey, over a four week restriction period only.

A longer trial carrying participants past restriction into structured reintroduction and maintenance, sized to detect quality of life differences between the diets.

Caveats worth holding

This is one outpatient clinic in one country, and the arms were small. The traditional advice group had 13 people in it.
The published abstract does not report the total group sizes, dropout or adherence checks, so those are not reflected here.
You cannot blind someone to what is on their plate. Participants did not know the name of their diet, but the food itself is a strong cue and the symptom and quality of life scores are self reported.
Four weeks is a short window for a condition that runs for years, and nobody was reassessed after the restriction period ended.